definiens: means, subject to the other provisions of this Ag reement and any USCommercialization Plan hereunder, the sum of the fo llowing costs and expenses incurred following the E ffective Dateby the Parties or their Affiliates, in the course o f the Commercialization of the Products in the US T erritory inaccordance with this Agreement during the applicabl e Calendar Quarter or the applicable Calendar Year, in each casethat are incurred in accordance with the US Commerc ialization Budget ( each as defined in the section l isted inparentheses below ): a. Blocking Third Party Intellectual Property Costs ( Section 1.12 ) ; b. Distribution Costs ( Exhibit A, Section ( 4 ) ) ; c. EAP Expenses ( Exhibit A, Section ( 5 ) ) ; d. Infinity Third Party Agreement Payments ( Section 1.83 ) ; e. Health Care Reform Fees ( Exhibit A, Section ( 6 ) ) ; f. Marketing Expenses ( Exhibit A, Section ( 7 ) ) ; g. Other Commercialization Costs ( Exhibit A, Sectio n ( 9 ) ) ; h. Product Trademark Costs ( Section 8.7.2(c)(iii ) ) ; i. Recall Expenses ( Exhibit A, Section ( 11 ) ) ; j. Regulatory Maintenance Costs ( Exhibit A, Section ( 12 ) ) ; k. Selling Expenses ( Exhibit A, Section ( 8) ) ; l. [ * * ] ; m. [ * * ] n. Shared Product Liability Costs ( Section 11.4.3 ) ; o. Alliance Manager Expenses ( ( Exhibit A, Section ( 2 ) ) ; and p. Supply Price of Products for Commercialization ( Exhibit A, Section ( 13 ) )